A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas-Reference-Cited by-同舟云学术

A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas

Published:2012-01-03 Issue:14 Volume:118 Page:3538-3548
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sinha Rajni,Kaufman Jonathan L.,Khoury Hanna Jean,King Nassoma,Shenoy Pareen J.,Lewis Carol,Bumpers Kevin,Hutchison-Rzepka Amanda,Tighiouart Mourad,Heffner Leonard T.,Lechowicz Mary Jo,Lonial Sagar,Flowers Christopher R.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26660/fullpdf

Reference43 articles.

1. CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma;Czuczman;Semin Oncol.,1999

2. Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma;Vose;Leuk Lymphoma.,2005

3. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group;Hiddemann;Blood.,2005

4. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma;Marcus;Blood.,2005

5. Determining the benefits of chemotherapy for achieving complete response in patients with untreated advanced stage follicular lymphoma: a systematic review and meta-analysis [abstract];Orina;Blood (ASH Annual Meeting Abstracts).,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guillain-Barré syndrome after bortezomib therapy in a child with relapsed acute lymphoblastic leukemia;Pediatric Hematology and Oncology;2021-08-09

2. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer;BMC Cancer;2021-07-05

3. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer;2020-08-21

4. A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors;Pediatric Blood & Cancer;2019-12-25

5. Weekly versus biweekly bortezomib given in patients with indolent non-Hodgkin lymphoma: A meta-analysis;PLOS ONE;2017-05-22